Judge issues mixed ruling on Shkreli attorney communications
21-08-2020
Shkreli says he isn’t responsible for Daraprim ‘monopoly’
30-07-2020
States join antitrust suit against ‘pharma bro’ Shkreli
16-04-2020
Mark Van Scyoc / Shutterstock.com
Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission (FTC).
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Martin Shkreli, Daraprim, Vyera Pharmaceuticals, Turing, FTC, antitrust, monopoly, pyrimethamine, pharma bro, Vyera, Phoenixus
